06.03.01 (IP Treatment Allocation) versus 11.02.03 Master Randomization List

Home › Forums › Where do I file…. ? › 06.03.01 (IP Treatment Allocation) versus 11.02.03 Master Randomization List

Tagged: 

Viewing 1 reply thread
  • Author
    Posts
    • July 21, 2022 at 3:00 pm #4700
      Christina Salinas
      Participant

      Hello,
      Looking for some guidance. What is the difference between 06.03.01 (IP Treatment Allocation Documentation) versus 11.02.03 (Master Randomization List)?

      Is 06.03.01 only applicable to blinded randomized trials?

      Thanks,
      Christina

    • July 25, 2022 at 4:13 pm #4704
      Vaibhav Funde
      Participant

      Hi Christina,
      Artifact 06.03.01 (IP Treatment Allocation Documentation) is related to Investigational Product related documentation, Zone 06 covers all types of log used for accountability and tracking of Investigational Product.
      Where Artifact 11.02.03 is related to Statistical programming Documentation generated for Investigational Product.
      Artifact 06.03.01 is used for filling documents related to IP Treatment Allocation Documentation Kit List, Randomization Envelopes, Randomization List.
      Artifact 11.02.03 is used for Master Randomization List created for study protocol which is The single source on the assignment of subjects to protocol specified groups. In blinded studies, this list remains blinded until its release following the final data lock.
      As per my understanding artifact 06.03.01 is applicable for all study which have randomization procedure.
      Hope so this information will help to distinguish between zone 06 related artifacts and zone 11 related artifacts.
      Thank you.
      With Regards.
      Vaibhav Funde.

  • Author
    Posts
Viewing 1 reply thread
  • You must be logged in to reply to this topic.